Cell kinetic in epithelium and stroma of benign prostatic hyperplasia

Journal of Urology

Volumn 158, Issue 1, 1997, Pages 217-221

  Claus, Siegfried ^b   Berges, Richard ^b   Senge, Theodor ^b   Schulze, Harald ^a,b  

^a KLINIKUM DORTMUND   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Apoptosis; BPH; Proliferation; Stromal growth

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; STROMA CELL;

EID: 0030915253     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199707000-00074     Document Type: Article

References (35)

1. Isaacs, J. T., Morton, R. A., Martikainen, P. and Isaacs, W. B.: Growth factors affecting normal and malignant prostatic cells. In: Growth Factors in Reproduction. Edited by D. W. Schomberg. New York: Springer Verlag, pp. 167-184, 1991.
2. Isaacs, J. T.: Antagonistic effect of androgen on prostatic cell death. Prostate, 5: 545, 1984.
3. Berges, R. R., Vukanovic, J., Epstein, J. I., Carmichel, M., Cisek, L., Johnson, D. E., Veltri, R. W., Walsh, P. C. and Isaacs, J. T.: Implication of cell kinetic changes during the progression of human prostate cancer. Clin. Can. Res., 1: 473, 1995.
4. Huggins, C. and Stevens, R. A.: The effect of castration on benign hypertrophy of the prostate in man. J. Urol., 43: 705, 1940.
5. Moore, R. A.: Benign hypertrophy and carcinoma of the prostate. Surgery, 16: 152, 1944.
6. Huggins, C.: The etiology of benign prostatic hypertrophy. Bull. N. Y. Acad. Med., 25: 696, 1947.
7. Berry, S. J., Coffey, D. S., Walsh, P. C. and Ewing, L. L.: The development of human benign prostatic hyperplasia with age. J. Urol., 132: 474, 1984.
8. Walsh, P. C.: Benign prostatic hyperplasia. In: Campbell's Urology. Edited by P. C. Walsh, R. F. Gittes, A. D. Perlmutter and T. A. Stamey. Fifth Edition. Philadelphia: W. B. Saunders, pp. 1248-1265, 1986.
9. Claus, S., Wrenger, M., Senge, T. and Schulze, H.: Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates. Urol. Res., 21: 305, 1993.
10. Kerr, J. F. R., Wyllie, A. H. and Currie, A. R.: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239, 1972.
11. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S. A.: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493, 1992.
12. Helpap, B.: Pathologie der ableitenden Harnwege und der Prostata. Berlin, Heidelberg, New York, London, Paris, Tokyo: Springer-Verlag, pp. 196-199, 1989.
13. Kuhar, M. J.: Receptor localization with the microscope. In: Neurotransmitter Receptor Binding. 2nd Edition. Edited by H. I. Yamamura, S. J. Enna and M. J. Kuhar. New York: Raven Press, pp. 153-175, 1985.
14. Hsu, S. -M., Raine, L. and Fanger, H.: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol., 75: 734, 1981.
15. Hsu, S. -M., Raine, L. and Fanger, H.: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577, 1981.
16. Spearman, C.: The proof and measurement of association between two things. Amer. J. Psychol., 15: 72, 1904.
17. Büning, H., Trenkler, G.: Nichtparametrische statistische Methoden. Berlin, New York: Walter de Gruyter, pp. 250-258, 1978.
18. Isaacs, J. T. and Coffey, D. S.: Etiology and disease process of benign prostatic hyperplasia. Prostate (Suppl.), 2: 33, 1989.
19. Coffey, D. S., Berry, S. J. and Ewing, L. L.: An overview of current concepts in the study of benign prostatic hyperplasia. In: Benign Prostatic Hyperplasia. NIH publication 87-2881. Edited by C. H. Rodgers, D. S. Coffey, G. Cunha, J. T. Grayback, F. Hinman and R. Horton. National Institutes of Health, Bethesda, Md., p. 1, 1985.
20. Tunn, S., Nass, R., Ekkernkamp, A., Schulze, H. and Krieg, M.: Evaluation of average life span of epithelial and stromal cells of human prostate by superoxide dismutase activity. Prostate, 15: 263, 1989.
21. Harman, D.: The aging process. Proc. Natl. Acad. Sci. USA, 78: 7124, 1981.
22. Fleming, J. E., Miquel, J., Cottrett, S. F., Yengoyan, L. S. and Economes, A. C.: Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontol., 28: 44, 1982.
23. Lippman, R. D.: Lipid peroxidation and metabolism in aging: a biological, chemical, and medical approach. Rev. Biol. Res. Aging, 1: 315, 1983.
24. Gensler, H. L., Hall, J. D. and Bernstein, H.: The DNA damage hypothesis of aging: importance of oxidative damage. In: Review of Biological Research in Aging, vol. 3. Edited by M. Rothstein, W. H. Adler, V. J. Christofalo, C. E. Finch, J. R. Florini and G. M. Martin. New York: Alan R. Liss, Inc., pp. 451-465, 1987.
25. McCord, J. M. and Fridovich, L: Superoxide dismutase. An enzyme function for erythrocuprein (hemocuprein). J. Biol. Chem., 244: 6049, 1969.
26. Fridovich, I.: Superoxide radical: an endogenous toxicant. Ann. Rev. Pharmacol. Toxicol., 23: 239, 1983.
27. Rohr, H. P. and Bartsch, G.: Human benign prostatic hyperplasia: a stromal disease? New perspectives by quantitative morphology. Urology, 14: 625, 1980.
28. Bartsch, G., Müller, H. R., Oberholzer, M. and Rohr, H. P.: Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J. Urol., 122: 487, 1979.
29. Isaacs, J. T.: Role of programmed cell death in carcinogenesis. Environ. Health Perspect., 101 (Suppl. 5): 27, 1993.
30. Wyllie, A. H., Kerr, J. F. R., Macaskill, I. A. M. and Currie, A. R.: Adrenocortical cell deletion: the role of ACTH. J. Pathol., 111: 85, 1973.
31. English, H. F., Kyprianou, N. and Isaacs, J. T.: Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate, 15: 233, 1989.
32. 2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate, 13: 103, 1988.
33. Martikainen, P. and Isaacs, J.: Role of calcium in the programmed death of rat prostatic glandular cells. Prostate, 17: 175, 1990.
34. Martikainen, P., Kyprianou, N., Tucker, R. W. and Isaacs, J. T.: Programmed death of nonproliferating androgen-independent prostatic cancer cells. Cancer Res., 51: 4693, 1991.
35. Isaacs, J. T., Lundmo, P. I., Berges, R., Martikainen, P., Kyprianou, N. and English, H. F.: Androgen regulation of programmed death of normal and malignant prostatic cells. J. Androl., 13: 457, 1992.